Home > Overview of Initiatives > Overview
In the school of pharmacy in Japan, 6- and 4-year courses were newly established in 2006. It is required for us to bring up successfully clinical pharmacists engaging in team approach at medical workplaces and skilled researchers engaging in drug discovery and development of medicine at pharmaceutical companies. In that context, natural medicine is an important area in the field of medical care. Our most urgent task is to bring up the pharmacy specialists in natural medicine and the research specialists in manufacturing pharmacy of natural medicine.
On the other hand, the school of pharmacy in China has two courses; one is Western medicine major and another is Chinese medicine major. Similarly, the school of pharmacy in South Korea has two courses; one is Western medicine major and another is Korean medicine (Natural medicine) major. It is required for them to develop highly skilled professionals such as pharmaceutical technicians and clinical pharmacists who are familiar with the fields of Western medicine and natural medicine.
The aim of this program is to develop pharmacists managing pharmaceutical treatment at medical workplaces and to develop researchers and technicians managing the drug quality control and drug research and development at pharmaceutical companies. The University of Toyama develops highly skilled professionals in the Ph.D. Program of the Graduate School of Medicine and Pharmaceutical Sciences for Education (Pharmaceutical Sciences) for the field of natural medicine where personnel training have particularly lagged. We will accept graduates of pharmaceutical universities in China, Korea, and other countries in addition to Japanese students into the program and develop human resources who specialize in knowledge of natural medicine and are familiar with various fields of pharmaceutical sciences. To achieve these plans, we will establish two Ph.D. courses (pharmacy and pharmaceutical sciences) for which the main area of specialization is natural medicine, in the Graduate School of Medicine and Pharmaceutical Sciences for Education (Pharmaceutical Sciences).
We will also conduct an internship program at the site management organizations (SMO) to provide experience in clinical trials in which our graduates take the initiative and in the management of physician-led clinical research. For international students, during the initial 1-year period, academic advisors and other instructors will provide support to enable students to become familiar with the Japanese language and customs. In addition, the students will attend the conduct tours of Japanese pharmaceutical companies and medical workplaces (together with first-year students in the Faculty of Pharmaceutical Sciences) to accumulate their learning experience.
We will prepare various internships based on the field of natural medicine and establish our internship system.
In Ph.D. Program of the Graduate School of Medicine and Pharmaceutical Sciences for Education (Pharmaceutical Sciences), we will eventually increase the proportion of international students to 20%, and develop human resources who are familiar with Japan, China, Korea and other countries.
We will develop human resources who are familiar with natural medicine and who are active at medical workplaces and pharmaceutical companies with their solid skills. We will try for the employment rate of 100%.
It can be expected that collaboration among universities and pharmaceutical companies in Japan, China, Korea and other countries will advance dramatically.
As a result of collaboration among Japan, China, Korea and other countries, it can be expected that the pharmaceutical treatment and drug development in the field of natural medicine, which is important for medical care, will advance and that the progress will serve as great contribution to society.
It can be expected to appear excellent professionals who are able to catch generally the information and knowledge concerning natural medicine in Japan, China, Korea and other countries, and to promote the multinational cooperation system in pharmaceutical innovation.
